Chenjia Xu

906 total citations · 1 hit paper
28 papers, 663 citations indexed

About

Chenjia Xu is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology and Molecular Biology. According to data from OpenAlex, Chenjia Xu has authored 28 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Chenjia Xu's work include Liver Disease and Transplantation (5 papers), Intensive Care Unit Cognitive Disorders (4 papers) and Corneal surgery and disorders (4 papers). Chenjia Xu is often cited by papers focused on Liver Disease and Transplantation (5 papers), Intensive Care Unit Cognitive Disorders (4 papers) and Corneal surgery and disorders (4 papers). Chenjia Xu collaborates with scholars based in United States, China and Netherlands. Chenjia Xu's co-authors include Thomas C. Chiles, Michael Naughton, Ying Yu, Mary F. Roberts, Jeffrey H. Chuang, Huaizhou Zhao, Dandan Wang, Dong Cai, Lu Zhang and Zhifeng Ren and has published in prestigious journals such as Nature Nanotechnology, The American Journal of Gastroenterology and Virology.

In The Last Decade

Chenjia Xu

28 papers receiving 653 citations

Hit Papers

Efficacy and safety of lebrikizumab in moderate-to-severe... 2023 2026 2024 2025 2023 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
    2023 72 citations Andrew Blauvelt, Jacob P. Thyssen et al. British Journal of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenjia Xu United States 12 165 164 156 88 77 28 663
Brunetta Porcelli Italy 14 26 0.2× 163 1.0× 21 0.1× 107 1.2× 10 0.1× 79 750
Rodney R. Walters United States 23 288 1.7× 707 4.3× 139 0.9× 56 0.6× 151 2.0× 50 1.4k
Lucia Terzuoli Italy 12 34 0.2× 189 1.2× 20 0.1× 112 1.3× 5 0.1× 67 733
Susan M. Daly United States 14 167 1.0× 194 1.2× 8 0.1× 53 0.6× 100 1.3× 29 833
S. Kashimura Japan 16 64 0.4× 243 1.5× 117 0.8× 84 1.0× 14 0.2× 75 838
Takayuki Shibata Japan 16 79 0.5× 407 2.5× 12 0.1× 47 0.5× 25 0.3× 65 964
Shyh‐Shin Chiou Taiwan 20 106 0.6× 337 2.1× 25 0.2× 33 0.4× 8 0.1× 80 971
Munekage Yamaguchi Japan 20 50 0.3× 309 1.9× 16 0.1× 211 2.4× 7 0.1× 91 1.3k
Mehmet Gökhan Çağlayan Türkiye 18 185 1.1× 285 1.7× 58 0.4× 66 0.8× 3 0.0× 61 705

Countries citing papers authored by Chenjia Xu

Since Specialization
Citations

This map shows the geographic impact of Chenjia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenjia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenjia Xu more than expected).

Fields of papers citing papers by Chenjia Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenjia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenjia Xu. The network helps show where Chenjia Xu may publish in the future.

Co-authorship network of co-authors of Chenjia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenjia Xu. A scholar is included among the top collaborators of Chenjia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenjia Xu. Chenjia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Chenjia, et al.. (2025). Bioinformatic Analysis of the Value of Mitophagy and Immune Responses in Corneal Endothelial Dysfunction. Current Issues in Molecular Biology. 47(8). 670–670. 1 indexed citations
2.
Yu, Yi, et al.. (2024). SIRT1 Activation Suppresses Corneal Endothelial–Mesenchymal Transition via the TGF-β/Smad2/3 Pathway. Current Issues in Molecular Biology. 46(12). 13846–13859. 2 indexed citations
3.
Yu, Y. L., Chenjia Xu, Minglu Ma, et al.. (2024). Protective effects of curcumin on corneal endothelial cell PANoptosis and monocyte adhesion induced by tumor necrosis factor-alpha and interferon-gamma in rats. Experimental Eye Research. 245. 109952–109952. 6 indexed citations
4.
Silverberg, Jonathan I., Thomas Bieber, Kilian Eyerich, et al.. (2024). 732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations. British Journal of Dermatology. 191(Supplement_2). 1 indexed citations
5.
Blauvelt, Andrew, Jacob P. Thyssen, Emma Guttman‐Yassky, et al.. (2023). Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials. British Journal of Dermatology. 188(6). 740–748. 72 indexed citations breakdown →
6.
Xu, Chenjia, et al.. (2023). Resveratrol regulates macrophage recruitment and M1 macrophage polarization and prevents corneal allograft rejection in rats. Frontiers in Medicine. 10. 1250914–1250914. 8 indexed citations
7.
Orman, Eric S., Chenjia Xu, Lauren Nephew, et al.. (2022). Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With Cirrhosis. Journal of Pain and Symptom Management. 63(6). 953–961. 5 indexed citations
8.
Desai, Archita P., Chenjia Xu, Marwan Ghabril, et al.. (2022). Confusion assessment method accurately screens for hepatic encephalopathy and predicts short-term mortality in hospitalized patients with cirrhosis. Metabolic Brain Disease. 38(5). 1749–1758. 2 indexed citations
9.
10.
Orman, Eric S., Marwan Ghabril, Archita P. Desai, et al.. (2021). Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clinical Gastroenterology and Hepatology. 20(6). e1426–e1437. 14 indexed citations
11.
12.
Dong, Chen, Shengjie Liao, Yu Zhang, et al.. (2020). Transcriptome‐wide study of the response of human trabecular meshwork cells to the substrate stiffness increase. Journal of Cellular Biochemistry. 121(5-6). 3112–3123. 17 indexed citations
13.
Li, Dandan, et al.. (2020). Identification and functional analysis of a novel missense mutation in GJA8, p.Ala69Thr. BMC Ophthalmology. 20(1). 461–461. 7 indexed citations
14.
Khan, Sikandar, Chenjia Xu, Heidi Lindroth, et al.. (2020). Decreasing Delirium Through Music: A Randomized Pilot Trial. American Journal of Critical Care. 29(2). e31–e38. 38 indexed citations
15.
Wang, Sophia Y., Chenjia Xu, Sujuan Gao, et al.. (2019). Critical Care Recovery Center: a model of agile implementation in intensive care unit (ICU) survivors. International Psychogeriatrics. 32(12). 1409–1418. 11 indexed citations
16.
Patidar, Kavish R., Chenjia Xu, Yao‐Wen Cheng, et al.. (2019). Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis. Clinical and Translational Gastroenterology. 10(9). e00075–e00075. 19 indexed citations
17.
Xu, Chenjia, Arlene R. Wyman, Manal Alaamery, et al.. (2016). Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes. International Immunopharmacology. 38. 223–232. 20 indexed citations
18.
Cai, Dong, Lu Ren, Huaizhou Zhao, et al.. (2010). A molecular-imprint nanosensor for ultrasensitive detection of proteins. Nature Nanotechnology. 5(8). 597–601. 298 indexed citations
19.
Gumina, Maria R., Chenjia Xu, & Thomas C. Chiles. (2010). Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E. Cell Cycle. 9(4). 820–828. 10 indexed citations
20.
Aligo, Jason, Chenjia Xu, Wei Sun Park, et al.. (2009). Endocytic Rab proteins are required for hepatitis C virus replication complex formation. Virology. 398(1). 21–37. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brunetta Porcelli Breakdown of academic impact, for papers by Rodney R. Walters Breakdown of academic impact, for papers by Lucia Terzuoli Breakdown of academic impact, for papers by Susan M. Daly Breakdown of academic impact, for papers by S. Kashimura Breakdown of academic impact, for papers by Takayuki Shibata Breakdown of academic impact, for papers by Shyh‐Shin Chiou Breakdown of academic impact, for papers by Munekage Yamaguchi Breakdown of academic impact, for papers by Mehmet Gökhan Çağlayan
Rankless by CCL
2026